Athersys, Inc.

United States of America

 
Total IP 9
Total IP Rank # 172,218
IP Activity Score 0/5.0    0
IP Activity Rank # 1,666,609
Stock Symbol ATHX (nasdaq)
ISIN US04744L1061
Market Cap. 367M  (USD)
Industry Biotechnology
Sector Healthcare

Patents

Trademarks

0 0
0 0
9 0
0
 
Last Patent 2012 - Tricyclic indeno-pyrrole derivat...
First Patent 1998 - Expression of endogenous genes b...

Latest Inventions, Goods, Services

2012 Invention Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators. The present invention gene...
2011 Invention Pyrazoles for the treatment of obesity and other cns disorders. This invention relates to compoun...
Invention 2c receptor ligands and uses thereof. 2c) is desired (e.g. addiction, anxiety, depression, obesit...
2010 Invention Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep di...
2008 Invention Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators. T...
2007 Invention Workflow applications. A facility is described for enabling workflow applications. The facility ...
Invention Pyrazoles for the treatment of obesity and other cns disorders. This invention relates to c...
Invention Mapc treatment of brain injuries and diseases. The invention relates to the treatment of various ...
Invention Mapc therapeutics without adjunctive immunosuppressive treatment. The invention relates to the tr...
Invention Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof. The...
Invention Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof. The prese...
2006 Invention Immunomodulatory properties of multipotent adult progenitor cells and uses thereof. Isolated cell...
Invention Culture of non-embryonic cells at high cell density. The present invention is directed to the cul...
Invention Use of a gsk-3 inhibitor to maintain potency of cultured cells. The present invention is directed...
2005 Invention 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and...
Invention Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof. The invention r...
Invention Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof. The invention relates ...
Invention Compositions and methods for non-targeted activation of endogenous genes. The present invention ...
Invention Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators. The present inventio...
Invention Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators. The present invention gen...
Invention Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof. Acrylic n-hydroxy im...
Invention Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof. Acylic n-hydroxy imi...
Invention Substituted azepine derivatives as serotonin receptor modulators. The present invention generally...
Invention Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive a...
Invention Substituted azepine derivatives as serotonin receptor modulators. The present invention ge...
2004 Invention Benzo⏧1, 3]dioxole compounds, pharmaceutical compositions thereof, and processes of making a...
Invention Enhanced engineered chromosome formation from alpha satellite with artificially increased density...
2003 Invention Methods for using osteocalcin. The present invention relates to methods for using osteocalcin. Th...
Invention Calcium-sensing receptor 2 (car2) and methods for using. The current disclosure provide a novel h...
Invention Benzo[1,3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and usi...
Invention compositions and methods for making mutations in cell lines and animals . The present ...
2002 Invention Methods for using adamts-12, an integrin and metalloprotease with thrombspondin motifs. The prese...
2000 Invention Compositions and methods for non-targeted activation of endogenous genes. The present invention i...
1999 Invention Compositions and methods for non-targeted activation of endogenous genes. The field of the invent...